CUMULATIVE RISKS OF FRACTURE IN PATIENTS USING ORAL GLUCOCORTICOIDS

CUMULATIVE RISKS OF FRACTURE IN PATIENTS USING ORAL GLUCOCORTICOIDS

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Van Staa, T, Geusens, P, Pols, H, De Laet, C, Leufkens, H, Cooper, C
Μορφή:	Journal article
Έκδοση:	2004

Παρόμοια τεκμήρια

A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids.
ανά: van Staa, T, κ.ά.
Έκδοση: (2005)

Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids.
ανά: van Staa, T, κ.ά.
Έκδοση: (2007)

Oral corticosteroids and fracture risk: relationship to daily and cumulative doses.
ανά: van Staa, T, κ.ά.
Έκδοση: (2000)

Fracture risk with intermittent high-dose oral glucocorticoid therapy.
ανά: De Vries, F, κ.ά.
Έκδοση: (2007)

Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.
ανά: van Staa, T, κ.ά.
Έκδοση: (2006)

Use of beta-blockers and risk of hip and vertebral fracture: relationships to daily and cumulative dose
ανά: De Vries, F, κ.ά.
Έκδοση: (2006)

Use of oral corticosteroids and risk of fractures.
ανά: Van Staa, T, κ.ά.
Έκδοση: (2000)

Children and the risk of fractures caused by oral corticosteroids.
ανά: van Staa, T, κ.ά.
Έκδοση: (2003)

Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
ανά: de Vries, F, κ.ά.
Έκδοση: (2007)

A simple clinical score for estimating the long-term risk of fracture in post-menopausal women.
ανά: van Staa, T, κ.ά.
Έκδοση: (2006)

PREDICTORS FOR VERTEBRAL FRACTURES AND FRACTURE THRESHOLD IN PATIENTS USING ORAL GLUCOCORTICOIDS
ανά: van Staa, T, κ.ά.
Έκδοση: (2003)

The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks.
ανά: van Staa, T, κ.ά.
Έκδοση: (2007)

Use of oral corticosteroids and risk of fractures. June, 2000.
ανά: Van Staa, T, κ.ά.
Έκδοση: (2005)

Bone loss and inhaled glucocorticoids.
ανά: van Staa, T, κ.ά.
Έκδοση: (2002)

Use of inhaled corticosteroids and risk of fractures.
ανά: van Staa, T, κ.ά.
Έκδοση: (2001)

Inhaled corticosteroids and risk of fractures
ανά: Van Staa, T, κ.ά.
Έκδοση: (2000)

Use of nonsteroidal anti-inflammatory drugs and risk of fractures.
ανά: van Staa, T, κ.ά.
Έκδοση: (2000)

The use of individual risks rather than population averages in cost-effectiveness modeling
ανά: Van Staa, T, κ.ά.
Έκδοση: (2006)

The use of individual risks rather than PopulationAverages in cost-effectiveness modeling
ανά: van Staa, T, κ.ά.
Έκδοση: (2006)

Risk of incident fracture is associated with dose, duration and recency of oral glucocorticoid exposure
ανά: Robinson, DE, κ.ά.
Έκδοση: (2018)

Not all patients are average: The importance of recognising patient heterogeneity
ανά: Van Staa, T, κ.ά.
Έκδοση: (2006)

Use of statins and risk of fractures.
ανά: van Staa, T, κ.ά.
Έκδοση: (2000)

The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.
ανά: van Staa, T, κ.ά.
Έκδοση: (2003)

Utility of medical and drug history in fracture risk prediction among men and women.
ανά: van Staa, T, κ.ά.
Έκδοση: (2002)

Not all patients are average: The importance of epidemiological data in pharmacoeconomic modeling
ανά: van Staa, T, κ.ά.
Έκδοση: (2006)

The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results.
ανά: Van Staa, T, κ.ά.
Έκδοση: (2000)

Use of oral corticosteroids and risk of fractures (reprinted from JBMR, vol. 15, pg. 993-1000, yr. 2000)
ανά: Van Staa, T, κ.ά.
Έκδοση: (2005)

The use of inhaled corticosteroids is not associated with an increased risk of fracture in children.
ανά: van Staa, T, κ.ά.
Έκδοση: (2001)

Are inhaled corticosteroids associated with an increased risk of fracture in children?
ανά: van Staa, T, κ.ά.
Έκδοση: (2004)

Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
ανά: Van Staa, T, κ.ά.
Έκδοση: (2003)

The limitations of using simple definitions of glucocorticoid exposure on the prediction of fracture risk
ανά: Robinson, D, κ.ά.
Έκδοση: (2018)

Does a fracture at one site predict later fractures at any other site?
ανά: van Staa, T, κ.ά.
Έκδοση: (2001)

Use of statins and risk of fractures.
ανά: van Staa, T, κ.ά.
Έκδοση: (2001)

Does a fracture at one site predict later fractures at other sites? A British cohort study.
ανά: van Staa, T, κ.ά.
Έκδοση: (2002)

Inhaled corticosteroids and hip fracture: disease or drugs?
ανά: van Staa, T, κ.ά.
Έκδοση: (2003)

Use of statins, risk of fracture and age-band bias
ανά: De Vries, F, κ.ά.
Έκδοση: (2006)

Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.
ανά: de Vries, F, κ.ά.
Έκδοση: (2007)

Diseases and drugs associated with osteoporosis predict fractures at different sites
ανά: van Staa, T, κ.ά.
Έκδοση: (2001)

Statins and fracture risk - Reply
ανά: van Staa, T, κ.ά.
Έκδοση: (2001)

Risk of fracture in patients with Guillain-Barre syndrome.
ανά: Pouwels, S, κ.ά.
Έκδοση: (2014)